Compare Cassava Sciences Inc (FLNA) vs KraneShares Hang Seng TECH Index ETF (KTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs KraneShares Hang Seng TECH Index ETF — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while KraneShares Hang Seng TECH Index ETF trades at $11.42 (market cap $46.53M). The key difference: KraneShares Hang Seng TECH Index ETF is the larger of the two by market cap, and Cassava Sciences Inc is more actively traded (759,018 versus 82,080). Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and KraneShares Hang Seng TECH Index ETF for 44 Days on average.
| FLNA | KTEC | |
|---|---|---|
Market Cap | $39.40M | $46.53M |
Volume | 759,018 | 82,080 |
Sector | Health | Sector/Thematic |
52-Week High | $4.64 | $18.73 |
52-Week Low | $0.68 | $11.41 |
Typical Hold Time | 37 Days | 44 Days |
Enterprise Value | -$43.28M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8136, down 7.01% today, with a bearish technical signal from moving averages. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent FDA approval to lift the clinical hold on simufilam for epilepsy research provides a positive catalyst, with patient screening expected by Q1 2027.
Despite operational losses and negative cash flow, analyst consensus is bullish with 8 buy ratings versus 4 hold. The key investment opportunity lies in the clinical progress of simufilam, while risks include sustained cash burn and reliance on successful drug development outcomes in a competitive biotech landscape.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About KraneShares Hang Seng TECH Index ETF
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →
